Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268133 | 12526813 | 3 | F | 20160119 | 20160801 | 20160705 | 20160812 | EXP | AU-CELGENEUS-AUS-2016013999 | CELGENE | 78.58 | YR | M | Y | 62.50000 | KG | 20160812 | OT | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268133 | 12526813 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 115027 | 125 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125268133 | 12526813 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 115027 | 100 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125268133 | 12526813 | 3 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 115027 | 100 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125268133 | 12526813 | 4 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 115027 | 100 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125268133 | 12526813 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 0 | 1000 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125268133 | 12526813 | 6 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 0 | 800 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125268133 | 12526813 | 7 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | 500 MILLIGRAM | Y | U | 0 | 800 | MG/M**2 | INJECTION FOR INFUSION | |||||
| 125268133 | 12526813 | 8 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 0 | 800 | MG/M**2 | INJECTION FOR INFUSION | ||||||
| 125268133 | 12526813 | 9 | C | perindopril | PERINDOPRIL | 1 | Oral | 0 | 5 | MG | UNKNOWN | QD | |||||||
| 125268133 | 12526813 | 10 | C | perindopril | PERINDOPRIL | 1 | Oral | 300 MILLIGRAM | 0 | 5 | MG | UNKNOWN | QD | ||||||
| 125268133 | 12526813 | 11 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | UNKNOWN | QD | |||||||
| 125268133 | 12526813 | 12 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 10 MILLIGRAM | 0 | UNKNOWN | QD | ||||||||
| 125268133 | 12526813 | 13 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | 10,000 AND 25,000 | 0 | CAPSULES | |||||||||
| 125268133 | 12526813 | 14 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 4 | MG | UNKNOWN | ||||||||
| 125268133 | 12526813 | 15 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 8 | MG | UNKNOWN | ||||||||
| 125268133 | 12526813 | 16 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 4 | G | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125268133 | 12526813 | 1 | Adenocarcinoma pancreas |
| 125268133 | 12526813 | 5 | Adenocarcinoma pancreas |
| 125268133 | 12526813 | 9 | Hypertension |
| 125268133 | 12526813 | 11 | Hypercholesterolaemia |
| 125268133 | 12526813 | 12 | Prophylaxis |
| 125268133 | 12526813 | 13 | Whipple's disease |
| 125268133 | 12526813 | 14 | Adenocarcinoma pancreas |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125268133 | 12526813 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125268133 | 12526813 | Febrile neutropenia | |
| 125268133 | 12526813 | Hepatic function abnormal | |
| 125268133 | 12526813 | Hyperglycaemia | |
| 125268133 | 12526813 | Pyrexia | |
| 125268133 | 12526813 | Urosepsis | |
| 125268133 | 12526813 | Viral infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125268133 | 12526813 | 1 | 20160115 | 20160204 | 0 | |
| 125268133 | 12526813 | 2 | 20160205 | 20160303 | 0 | |
| 125268133 | 12526813 | 3 | 20160304 | 20160311 | 0 | |
| 125268133 | 12526813 | 4 | 20160318 | 20160331 | 0 | |
| 125268133 | 12526813 | 5 | 20160115 | 20160204 | 0 | |
| 125268133 | 12526813 | 6 | 20160205 | 20160303 | 0 | |
| 125268133 | 12526813 | 7 | 20160304 | 20160311 | 0 | |
| 125268133 | 12526813 | 8 | 20160318 | 20160331 | 0 | |
| 125268133 | 12526813 | 9 | 1998 | 20160311 | 0 | |
| 125268133 | 12526813 | 10 | 20160621 | 0 | ||
| 125268133 | 12526813 | 11 | 1999 | 0 | ||
| 125268133 | 12526813 | 12 | 1997 | 20160311 | 0 | |
| 125268133 | 12526813 | 13 | 20151119 | 0 | ||
| 125268133 | 12526813 | 15 | 20160215 | 20160222 | 0 | |
| 125268133 | 12526813 | 16 | 20160212 | 20160222 | 0 |